Patents - MM&M - Medical Marketing and Media


J&J, Vivus patent suit ends

J&J subsidiary Janssen has abandoned its patent lawsuit over the anti-seizure medication topiramate, which is part of Vivus’s prescription weight-loss drug Qsymia.

Eisai sues FDA for more patent life

The Japanese drugmaker is looking to add as much as a year onto the patent life of some of its drugs after the DEA dragged out their scheduling decisions.

Generic Viagra floods Brazil

The generic ED pills sell for five cents less than Pfizer’s branded blue pill, but the undercutting is a bit deeper.